Post-surgical · Menopause
Surgical menopause: after oophorectomy, what happens next
Bilateral oophorectomy — removing both ovaries — causes an instant, complete drop in estrogen and testosterone. There is no perimenopause runway. Symptoms hit within days, and long-term consequences without HRT are substantial. For most women under 45, HRT is not optional.
The long-term stakes without HRT
- Cardiovascular disease risk up 80–120% if under 45
- Dementia risk elevated, especially if under 45
- Osteoporosis accelerated
- All-cause mortality elevated
- Sexual dysfunction, mood disorders, cognitive decline
Treatment framework
- Start HRT within days of surgery — do not wait for symptoms
- Transdermal estradiol at replacement dose (0.075–0.1 mg patch)
- No progesterone needed if uterus removed (unless endometriosis history)
- Consider testosterone if libido/energy remain low
- Continue at least until age 51; often longer
Frequently asked questions
How is surgical menopause different?
Sudden and severe. Estrogen goes from premenopausal levels to near-zero overnight, along with 50% of testosterone production. Symptoms are more intense than natural menopause.
Do I need HRT after oophorectomy?
Under 45: yes, unless contraindicated. 45–50: strongly recommended. 50+: individualized based on symptoms and risk.
What about testosterone after oophorectomy?
Ovaries produce ~50% of a woman's testosterone. Consider adding testosterone if libido, energy, or motivation remain flat on estrogen alone.
Was my ovariectomy necessary?
For hormone-positive cancer, high-penetrance genetic risk (BRCA), or severe endometriosis: yes. For benign disease, ovarian conservation is increasingly favored.
What if I had a hysterectomy but kept my ovaries?
You went through menopause at a normal age but without periods to mark it. Symptoms and treatment are the same as natural menopause.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Explore Kindr Health
Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Written and medically reviewed by the Kindr Health Clinical Team · Published 2026-06-19 · Last reviewed 2026-07-01. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.